{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:09:10Z","timestamp":1791504550797,"version":"4.3.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction and hypothesis<\/jats:title>\n                <jats:p>Our aim was to compare the mid-term results of native tissue, biological xenograft and polypropylene mesh surgery for women with vaginal wall prolapse.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 1348 women undergoing primary transvaginal repair of an anterior and\/or posterior prolapse were recruited between January 2010 and August 2013 from 35 UK centres. They were randomised by remote allocation to native tissue surgery, biological xenograft or polypropylene mesh. We performed both 4- and 6-year follow-up using validated patient-reported outcome measures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>At 4 and 6 years post-operation, there was no clinically important difference in Pelvic Organ Prolapse Symptom Score for any of the treatments. Using a strict composite outcome to assess functional cure at 6 years, we found no difference in cure among the three types of surgery. Half the women were cured at 6 years but only 10.3 to 12% of women had undergone further surgery for prolapse. However, 8.4% of women in the mesh group had undergone further surgery for mesh complications. There was no difference in the incidence of chronic pain or dyspareunia between groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>At the mid-term outcome of 6 years, there is no benefit from augmenting primary prolapse repairs with polypropylene mesh inlays or biological xenografts. There was no evidence that polypropylene mesh inlays caused greater pain or dyspareunia than native tissue repairs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00192-022-05308-0","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T15:06:12Z","timestamp":1661526372000},"page":"67-78","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["PROSPECT: 4- and 6-year follow-up of a randomised trial of surgery for vaginal prolapse"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6029-7948","authenticated-orcid":false,"given":"Fiona M.","family":"Reid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Aucott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathryn M. A.","family":"Glazener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Elders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hemming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin G.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R. B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Kilonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwayne","family":"Boyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Norrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Breeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"[for the PROSPECT study group]","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"issue":"6","key":"5308_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00192-017-3512-3","volume":"29","author":"AL Milani","year":"2018","unstructured":"Milani AL, Damoiseaux A, IntHout J, Kluivers KB, Withagen MIJ. Long-term outcome of vaginal mesh or native tissue in recurrent prolapse: a randomized controlled trial. Int Urogynecol J. 2018;29(6):847\u201358.","journal-title":"Int Urogynecol J"},{"issue":"4","key":"5308_CR2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00192-019-04073-x","volume":"31","author":"L Allegre","year":"2020","unstructured":"Allegre L, Callewaert G, Alonso S, Cornille A, Fernandez H, Eglin G, et al. Long-term outcomes of a randomized controlled trial comparing trans-obturator vaginal mesh with native tissue repair in the treatment of anterior vaginal wall prolapse. Int Urogynecol J. 2020;31(4):745\u201353.","journal-title":"Int Urogynecol J"},{"issue":"4","key":"5308_CR3","first-page":"501","volume":"89","author":"AL Olsen","year":"1997","unstructured":"Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997 APR. 1997;89(4):501\u20136.","journal-title":"Obstet Gynecol 1997 APR"},{"key":"5308_CR4","unstructured":"The Department of Economic and Social Affairs of the United Nations. World Population Ageing. 2017; Available at: https:\/\/www.un.org\/en\/development\/desa\/population\/publications\/pdf\/ageing\/WPA2017_Highlights.pdf. Accessed 22 June, 2021."},{"key":"5308_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12546-016-9178-8","volume":"34","author":"G Leeson","year":"2017","unstructured":"Leeson G. The impact of mortality development on the number of centenarians in England and Wales. J Pop Research. 2017;34:1\u201315.","journal-title":"J Pop Research"},{"issue":"389","key":"5308_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0140-6736(16)31596-3","volume":"28","author":"C Glazener","year":"2017","unstructured":"Glazener C, Breeman S, Elders A, Hemming C, Cooper K, Freeman R, et al. Mesh, graft, or standard repair for women having primary transvaginal anterior or posterior compartment prolapse surgery: two parallel-group, multicentre, randomised, controlled trials (PROSPECT). Lancet. 2017;28(389):381\u201392.","journal-title":"Lancet"},{"key":"5308_CR7","doi-asserted-by":"crossref","unstructured":"Reid F, Elders A, Breeman S, Freeman RM and the PROSPECT study group. How common are complications following polypropylene mesh, biological xenograft and native tissue surgery for pelvic organ prolapse? A secondary analysis from the PROSPECT trial. BJOG 2021; In press.","DOI":"10.1111\/1471-0528.16897"},{"key":"5308_CR8","unstructured":"First Do No Harm. The report of the Independent Medicines and Medical Devices safety Review. 2020; Available at: https:\/\/www.immdsreview.org.uk\/downloads\/IMMDSReview_Web.pdf. Accessed 5 August, 2020."},{"issue":"95","key":"5308_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20950","volume":"20","author":"C Glazener","year":"2016","unstructured":"Glazener C, Breeman S, Elders A, Hemming C, Cooper K, Freeman R, et al. Clinical effectiveness and cost-effectiveness of surgical options for the management of anterior and\/or posterior vaginal wall prolapse: two randomised controlled trials within a comprehensive cohort study - results from the PROSPECT Study. Health Technol Assess. 2016;20(95):1\u2013452.","journal-title":"Health Technol Assess"},{"issue":"5","key":"5308_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00192-012-1726-y","volume":"23","author":"P Toozs-Hobson","year":"2012","unstructured":"Toozs-Hobson P, Freeman R, Barber M, Maher C, Haylen B, Athanasiou S, et al. An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for reporting outcomes of surgical procedures for pelvic organ prolapse. Int Urogynecol J. 2012;23(5):527\u201335.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"5308_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1471-0528.2008.01903.x","volume":"116","author":"S Hagen","year":"2009","unstructured":"Hagen S, Glazener C, Sinclair L, Stark D, Bugge C. Psychometric properties of the pelvic organ prolapse symptom score. Bjog-an Int J Obstet Gynaecol. 2009;116(1):25\u201331.","journal-title":"Bjog-an Int J Obstet Gynaecol"},{"key":"5308_CR12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095\u2013108.","journal-title":"Med Care"},{"issue":"5","key":"5308_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00192-009-1069-5","volume":"21","author":"S Srikrishna","year":"2010","unstructured":"Srikrishna S, Robinson D, Cardozo L. Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse. Int Urogynecol J. 2010;21(5):523\u20138.","journal-title":"Int Urogynecol J"},{"key":"5308_CR14","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S0022-5347(05)00348-4","volume":"175","author":"P Abrams","year":"2006","unstructured":"Abrams P, Avery K, Gardener N, Donovan J. The ICIQ Advisory Board. The International Consultation on Incontinence Modular Questionnaire: www.iciq.net. J Urol. 2006;175:1063\u20136.","journal-title":"J Urol"},{"issue":"10","key":"5308_CR15","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s11255-020-02503-0","volume":"52","author":"JTN Tamanini","year":"2020","unstructured":"Tamanini JTN, Reis LO, da Mota Tamanini MM, Aquino Castro R, Sartori MGF, Girao MJBC. No mesh versus mesh in the treatment of anterior vaginal wall prolapse: prospective, randomised, controlled trial, long-term follow-up. Int Urol Nephrol. 2020;52(10):1839\u201344.","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"5308_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/SPV.0000000000000524","volume":"25","author":"S Iyer","year":"2019","unstructured":"Iyer S, Seitz M, Tran A, Scalabrin Reis R, Botros C, Lozo S, et al. Anterior Colporrhaphy with and Without Dermal Allograft: A Randomized Control Trial with Long-Term Follow-Up. Female Pelvic Med Reconstruct Surg. 2019;25(3):206\u201312.","journal-title":"Female Pelvic Med Reconstruct Surg"},{"issue":"10","key":"5308_CR17","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00192-013-2075-1","volume":"24","author":"R De Tayrac","year":"2013","unstructured":"De Tayrac R, Cornille A, Eglin G, Guilbaud O, Mansoor A, Alonso S, et al. Comparison between trans-obturator trans-vaginal mesh and traditional anterior colporrhaphy in the treatment of anterior vaginal wall prolapse: Results of a French RCT. Int Urogynecol J. 2013;24(10):1651\u201361.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"5308_CR18","first-page":"10","volume":"175","author":"RC Bump","year":"1996","unstructured":"Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JOL, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Obstet Gynecol 1996 JUL. 1996;175(1):10\u20137.","journal-title":"Obstet Gynecol 1996 JUL"},{"issue":"7","key":"5308_CR19","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00192-015-2939-7","volume":"27","author":"P Heinonen","year":"2016","unstructured":"Heinonen P, Aaltonen R, Joronen K, AlaNissila S. Long-term outcome after transvaginal mesh repair of pelvic organ prolapse. Int Urogynecol J. 2016;27(7):1069\u201374.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"5308_CR20","doi-asserted-by":"publisher","first-page":"12015","DOI":"10.1038\/s41598-017-11821-w","volume":"7","author":"K Keltie","year":"2017","unstructured":"Keltie K, Elneil S, Monga A, Patrick H, Powell J, Campbell B, et al. Complications following vaginal mesh procedures for stress urinary incontinence: an 8 year study of 92,246 women. Sci Rep. 2017;7(1):12015.","journal-title":"Sci Rep"},{"issue":"6","key":"5308_CR21","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00192-015-2913-4","volume":"27","author":"JR Miklos","year":"2016","unstructured":"Miklos JR, Chinthakanan O, Moore RD, Mitchell GK, Favors S, Karp DR, et al. The IUGA\/ICS classification of synthetic mesh complications in female pelvic floor reconstructive surgery: a multicenter study. Int Urogynecol J. 2016;27(6):933\u20138.","journal-title":"Int Urogynecol J"},{"key":"5308_CR22","doi-asserted-by":"crossref","unstructured":"National Institute for Health and Care Excellence (NICE). Urinary incontinence and pelvic organ prolapse in women: management. Clinical guideline [NG123]. 2019; Available at: https:\/\/www.nice.org.uk\/guidance\/ng123. Accessed 20th May, 2020.","DOI":"10.1111\/bju.14763"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-022-05308-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-022-05308-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-022-05308-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T13:04:41Z","timestamp":1673442281000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-022-05308-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["5308"],"URL":"https:\/\/doi.org\/10.1007\/s00192-022-05308-0","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"assertion":[{"value":"25 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PROSPECT was approved by the North of Scotland Research Ethics Committee (NOSRES) on 7th July 2009 (REC reference number 09\/SO802\/56).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Details of ethics approval"}},{"value":"Professor Freeman reports previous (not in the last 5-years) speaker fees for Astellas and Pfizer. All other authors declare that they have no conflict of interest.Mary Kilonzo is the current Health Economics Editor of the Cochrane Incontinence Group.Professor Norrie declares grants from University of Aberdeen and grants from University of Edinburgh during the conduct of the study and membership of the following NIHR boards: Efficacy and Mechanism Evaluation (EME) Board; CPR decision-making committee; HTA Commissioning Board; HTA Commissioning Sub-Board (EOI); HTA Funding Boards Policy Group; HTA General Board; HTA Post-Board funding teleconference; NIHR CTU Standing Advisory Committee; NIHR HTA & EME Editorial Board; Pre-exposure Prophylaxis Impact Review Panel.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}